Kyleena 19.5 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FCPE4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,144
Award facts
- Contract value 100% obligated
- $12,143.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,143.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Kyleena 19.5 mg contraceptive systems. The award, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036.
The PPV-G GEN V is part of the broader $30.3 billion pharmaceutical supply strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. As a prime vendor under this strategic acquisition vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to the Department of Defense. The company's established performance across multiple delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, with no subcontractors involved in this award.
Quick answers
Who was awarded contract SPE2DR26FCPE4?
SPE2DR26FCPE4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FCPE4 worth?
The government has obligated $12,144 on SPE2DR26FCPE4.
Is contract SPE2DR26FCPE4 an order under another contract?
Yes. SPE2DR26FCPE4 is a delivery order under SPE2DR25D9131, an indefinite delivery contract.
Was contract SPE2DR26FCPE4 competed?
The extent of competition for SPE2DR26FCPE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award